Affiliation:
1. Federal Service on Customers' Rights Protection and Human Well-being Surveillance
2. Children’s Republican Hospital
3. Bashkir State Medical University
Abstract
The aim of the present study was to evaluate exocrine pancreatic function in children with type 1 diabetes mellitus during the course of the disease.Fecal elastase varied between 24.4 and 169.6 μg /g (median 134.5 μg /g) in children with type 1 DM and concomitant PEI. Number of children with diarrhea was not significantly different between children with low pancreatic elastase levels and those with normal levels (43.0% versus 35.5%, p=0.359). The remainder of the children with type 1 DM had fecal elastase-1 levels between 201.4 and 810.5 μg /g stool (median 650.7 μg /g). Differences between the type 1 DM patients without PEI and the comparison group were not significant (p=0.112).Median daily fecal fat excretion in type 1 DM patients with PEI was 8.31 g/day (min-mах 7.81–9.21 g/day), which was significantly higher than in type 1 DM children without PEI (3.87 g/day; min-mах 2.97–6.33 g/day; р= 0.0003). There was no significant difference in daily fecal fat excretion between children with type 1 DM without signs of PEI and children in the control group (2.91 g/d; min-max: 2.31–5.74 g/d; р= 0.091).The results of this study demonstrate PEI in children with long-standing type 1 DM.Fecal elastase-1 concentration significantly correlates with duodenal exocrine elastase output. Fecal elastase-1 levels have a good correlation with fecal fat excretion, which was measured by employing the acid steatocrit test.
Publisher
LLC Global Media Technology
Subject
Gastroenterology,Hepatology
Reference38 articles.
1. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 8th edition, 2017. Available at: http://www.diabetesatlas.org. Access 05.05.2022.
2. Simmons K. M., Michels A. W. Type 1 diabetes: A predictable disease. World J Diabetes. 2015;6(3):380–390. doi:10.4239/wjd.v6.i3.380.
3. Andren-Sandberg A., Hardt P. D. Second Giessen International Workshop on Interactions of Exocrine and Endocrine Pancreatic Diseases. Castle of Rauischholzhausen of the Justus- Liebig- university, Giessen (Rauischholzhausen), Germany. March 7–8, 2008. JOP. 2008 Jul 10;9(4):541–75. PMID: 18648151.
4. Keller J., Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut. 2005 Jul;54 Suppl 6 (Suppl 6): vi1–28. doi: 10.1136/gut.2005.065946.
5. Czakó L., Hegyi P., Rakonczay Z. Jr, Wittmann T., Otsuki M. Interactions between the endocrine and exocrine pancreas and their clinical relevance. Pancreatology. 2009;9(4):351–9. doi: 10.1159/000181169.